< Back to latest news & events

Event

Medical Technology Ireland 2022

August 2022

Medical Technology Ireland Conference 2022 will be held on 21-22 September at the Galway Racecource.

Medical Technology Ireland is a new high-profile National and International event attracting global suppliers to the crème of the Irish Medical Device Industry.

What’s on at Medical Technology Ireland 2022?

  • Over 220 global suppliers exhibiting
  • Inspiring and educational two-day Conference sessions
  • Highly popular Women in MedTech Forum
  • Unmissable Research & Innovation Showcase, in association with ATU
  • Italian Pavilion incorporating 10 Italian supply chain companies
  • Free Meetings Programme for exhibitors and visitors
  • Unrivalled networking and business opportunities

HGF Patent Director Marie Walsh will be speaking on Wednesday 21st September on ‘Relating your IP to your Business: Strengthening your Investor Pitch‘.

FIND OUT MORE

Attendees

Marie
Walsh

Latest updates

Polymorphs: Clearing the Inventive Step Hurdle at the European Patent Office (EPO)

Polymorphic forms of active pharmaceutical ingredients (APIs) can represent commercially valuable compound subject matter and can be critical to providing necessary drug product characteristics and performance. However, patenting polymorphs is …

Read article

IQPC Global US Exchange

HGF are proud ‘Silver Plus’ sponsors of the IQPC Global US Exchange, at the Austin Marriot South, Texas. The IQPC Global US Exchange will be held at the Austin Marriot …

Read article

Update on the Precision Breeding Act 2023: details emerge of the new simplified regulatory pathway for gene edited plant and animal derived food and feed products

The Genetic Technology (Precision Breeding) Act 2023 could come into force as early as spring 2025. It empowers the Food Standards Agency (FSA) to create a new simplified regulatory pathway …

Read article

Court of Appeal Decision Upholds Invalidity of Patent Due to Amendment Identifying Embodiment as Outside the Scope of the Claims

In a case that highlights the challenges arising due to post-grant amendments, and in particular interpretation of the claims in view of the description, the Court of Appeal in Ensygnia …

Read article

UPC Court of Appeal clarifies approach for interpreting claims with “obvious” errors

Alexion Pharmaceuticals, Inc. v Samsung Bioepis NL B.V. [UPC_CoA_402/2024] –Court of Appeal of the UPC (Grabinski, Blok, Gougé, Enderlin, Hedberg) – 20 December 2024 Alexion Pharmaceuticals, Inc. v Amgen Technology …

Read article

IP Ingredients: Winter Case Law Review 2024

As the nights draw in and the frenzy to finish everything off before the holiday season reaches its peak, it’s time to take a break, grab your favourite hot beverage …

Read article
See all updates